Pharma.Aero welcomes Qatar Airways Cargo and isothermal solutions provider EMBALL’ISO as the organisation’s new Full Member and Associate Partner respectively.
Pharma.Aero has received growing interest by different stakeholders in the pharma air cargo supply chain to be part of the organisation, especially in current times when the air cargo industry plays a critical role in transporting life-saving medical products and Covid-19 vaccines globally.
Nathan De Valck, Chairman of Pharma.Aero, said, “In the past months, though they were volatile for the entire industry, we expanded our global network and raised awareness of the need for global collaboration within the industry. The onboarding of Qatar Airways Cargo – one of the world’s leading cargo carriers – underlines our worldwide impact as a neutral collaboration platform for the global air cargo industry and pharma and life science sector.”
Guillaume Halleux, Chief Officer Cargo at Qatar Airways said, “Collaboration is vital to strengthen the pharma supply chain integrity. The full membership with Pharma.Aero will allow us to share and receive market knowledge and also collaborate with different air cargo stakeholders in the supply chain which will ultimately lead to continuous improvement of life science, medtech and the pharma air cargo supply chain. We look forward to collaborating with Pharma.Aero members and excel in offering a reliable end-to-end air transport and seamless cool chain.”
“As the pioneer of Pallet Shipper and Isothermal “Reuse and Reverse Logistics”, we are very pleased to join the Pharma Aero Network to help in making pharmaceutical shipments safer, less expensive and more environmental-friendly,” added Yann Martin, Global Sales Director at EMBALL’ISO.